Skip to content

Effectiveness of Physiotherapy for Chronic Shoulder Pain

Efficacy and Cost-effectiveness of Physiotherapy for Chronic Rotator Cuff Pathology

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00415441
Enrollment
120
Registered
2006-12-22
Start date
2004-03-31
Completion date
2008-09-30
Last updated
2013-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Keywords

physiotherapy, exercise, manual therapy, shoulder pain, rotator cuff

Brief summary

The purpose of this study is to investigate whether a physiotherapy program reduces pain and improves disability and quality-of-life in people with chronic shoulder pain. The main study hypotheses are that (i) A 10-week physiotherapy treatment will result in significantly greater reductions in pain and disability than placebo treatment in individuals with chronic shoulder pain (ii) Improvements in pain and disability following a 10-week physiotherapy treatment will be maintained at a 3-month follow-up.

Detailed description

Chronic rotator cuff pathology (CRCP) is a common cause of musculoskeletal morbidity in the community. Physiotherapy is often the first line of management for this condition. However, the effectiveness of physiotherapy for CRCP has not been well studied. Thus this project primarily aims to investigate the effect of a multimodality physiotherapy program to treat CRCP where effect is measured in terms of pain, disability and health-related quality of life. The secondary aim is to evaluate the cost-effectiveness of physiotherapy as a treatment for CRCP. Comparison: physiotherapy program comprising stretches, exercises, manual techniques versus placebo physiotherapy

Interventions

PROCEDUREPlacebo physiotherapy treatment

Sponsors

National Health and Medical Research Council, Australia
CollaboratorOTHER
University of Melbourne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of CRCP as evident by symptoms and signs including pain on active abduction or external rotation and positive impingement test; * symptoms of pain in shoulder for \> 3 months; * average movement pain \> 3 on a 10 cm visual analogue scale; * aged ≥ 18 years; * able to understand written and spoken English.

Exclusion criteria

* severe pain at rest, defined as \> 7 on a visual analogue scale; * global restriction of shoulder movements; * systemic inflammatory joint disease; * x-ray evidence of shoulder osteoarthritis or fracture; * calcification about the shoulder joint; * reason to suspect a complete rotator cuff rupture (eg. weakness of arm elevation, a positive drop arm sign, a high riding humerus visible on x-ray or a complete tear on ultrasound); * previous shoulder surgery on affected arm; * physiotherapy, corticosteroid injection or hydrodilatation for shoulder in past 3 months; * commenced non-steroidal antiinflammatory medication (NSAIDs) or conservative intervention in past 2 weeks.

Design outcomes

Primary

MeasureTime frame
Shoulder Pain and Disability IndexBaseline and 11 weeks
Participant perceived global rating of change post treatment11 weeks

Secondary

MeasureTime frame
Australian Quality of Life Index at followupBaseline, 11 weeks and 22 weeks
Isometric Shoulder strength using manual muscle tester post treatment and followupBaseline, 11 weeks and 22 weeks
Shoulder Pain and Disability Index at followup22 weeks
Cost effectiveness analysisBaseline, 11 weeks and 22 weeks
Participant assessment of average pain and restriction of activity post treatment and followupBaseline, 11 weeks and 22 weeks
Participant perceived global rating of change at followup22 weeks

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026